Drug Interaction Between Ciprofloxacin and Azithromycin

Pharmacokinetic Profile

Azithromycin does not interact with the cytochrome P450 system, making it the preferred macrolide when drug interactions are a concern, according to the Infectious Diseases Society of America 1, 2, 3.
Neither ciprofloxacin nor azithromycin significantly inhibit or induce major metabolic pathways that would affect each other's concentrations, as reported by the European Respiratory Society 1, 2.
Azithromycin may inhibit P-glycoprotein (P-gp), but this does not affect ciprofloxacin metabolism, as noted by the National Cancer Institute 5.

Both ciprofloxacin and azithromycin independently prolong the QT interval and carry risk of sudden cardiac death, according to the American Heart Association 1, 2, 3.
Before combining these agents, correct electrolyte abnormalities (hypokalemia and hypomagnesemia) as these exacerbate QT prolongation, as recommended by the National Cancer Institute and the American College of Cardiology 5, 4.
Consider baseline ECG monitoring when concurrent medications that prolong QTc are being used, as suggested by the European Respiratory Society and the Infectious Diseases Society of America 1, 2, 3.
Avoid this combination in patients with pre-existing QT prolongation, cardiac arrhythmias, or those taking other QT-prolonging medications, as advised by the National Cancer Institute 5.

Ensure cardiac risk assessment is performed, including review of baseline QTc and electrolytes, before co-administering ciprofloxacin and azithromycin, as recommended by the American College of Cardiology and the National Cancer Institute 5, 4.
Avoid co-administration in patients with hepatic or renal impairment, which may increase drug levels and associated risks, as noted by the American College of Clinical Pharmacy 4.
Monitor for cardiac symptoms including palpitations, syncope, or dizziness, when co-administering ciprofloxacin and azithromycin, as suggested by the National Cancer Institute 5.
Consider whether both antibiotics are truly necessary, as monotherapy is often sufficient for most infections, according to the International Society of Travel Medicine 6.